UNLABELLED: The tight junction (TJ) marker occludin is a 4-transmembrane domain (TMD) protein with unclear physiological and pathological functions, interacting with other TJ proteins. It oligomerizes and is redox sensitive. However, oligomerization sites and mechanisms are unknown. AIMS: To identify hypoxia-sensitive binding sites, we investigated the consequences of amino-acid substitutions of highly conserved cysteines in human occludin, under normal and hypoxic incubations. RESULTS: (i) The extracellular loop 2 (ECL2) showed homophilic trans- and cis-association between opposing cells and along the cell membrane, respectively, caused by a loop properly folded via an intraloop disulfide bridge between the shielded C216 and C237. Hypoxia and reductants prevented the associations. (ii) C82 in TMD1 directly cis-associated without disulfide formation. (iii) C76 in TMD1 and C148 in TMD2 limited the trans-interaction; C76 also limited occludin-related paracellular tightness and changed the strand morphology of claudin-1. (iv) The diminished binding strength found after substituting C82, C216, or C237 was accompanied by increased occludin mobility in the cell membrane. INNOVATION: The data enable the first experimentally proven structural model of occludin and its homophilic interaction sites, in which the ECL2, via intraloop disulfide formation, has a central role in occludin's hypoxia-sensitive oligomerization and to regulate the structure of TJs. CONCLUSION: Our findings support the new concept that occludin acts as a hypoxiasensor and contributes toward regulating the TJ assembly redox dependently. This is of pathogenic relevance for tissue barrier injury with reducing conditions. The ECL2 disulfide might be a model for four TMD proteins in TJs with two conserved cysteines in an ECL.
UNLABELLED: The tight junction (TJ) marker occludin is a 4-transmembrane domain (TMD) protein with unclear physiological and pathological functions, interacting with other TJ proteins. It oligomerizes and is redox sensitive. However, oligomerization sites and mechanisms are unknown. AIMS: To identify hypoxia-sensitive binding sites, we investigated the consequences of amino-acid substitutions of highly conserved cysteines in humanoccludin, under normal and hypoxic incubations. RESULTS: (i) The extracellular loop 2 (ECL2) showed homophilic trans- and cis-association between opposing cells and along the cell membrane, respectively, caused by a loop properly folded via an intraloop disulfide bridge between the shielded C216 and C237. Hypoxia and reductants prevented the associations. (ii) C82 in TMD1 directly cis-associated without disulfide formation. (iii) C76 in TMD1 and C148 in TMD2 limited the trans-interaction; C76 also limited occludin-related paracellular tightness and changed the strand morphology of claudin-1. (iv) The diminished binding strength found after substituting C82, C216, or C237 was accompanied by increased occludin mobility in the cell membrane. INNOVATION: The data enable the first experimentally proven structural model of occludin and its homophilic interaction sites, in which the ECL2, via intraloop disulfide formation, has a central role in occludin's hypoxia-sensitive oligomerization and to regulate the structure of TJs. CONCLUSION: Our findings support the new concept that occludin acts as a hypoxiasensor and contributes toward regulating the TJ assembly redox dependently. This is of pathogenic relevance for tissue barrier injury with reducing conditions. The ECL2 disulfide might be a model for four TMD proteins in TJs with two conserved cysteines in an ECL.
Authors: Rebecca M Rentea; Jennifer L Liedel; Scott R Welak; Laura D Cassidy; Alan N Mayer; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay Journal: J Pediatr Surg Date: 2012-06 Impact factor: 2.545
Authors: Philipp Berndt; Lars Winkler; Jimmi Cording; Olga Breitkreuz-Korff; André Rex; Sophie Dithmer; Valentina Rausch; Rosel Blasig; Matthias Richter; Anje Sporbert; Hartwig Wolburg; Ingolf E Blasig; Reiner F Haseloff Journal: Cell Mol Life Sci Date: 2019-02-07 Impact factor: 9.261
Authors: Lars Winkler; Rosel Blasig; Olga Breitkreuz-Korff; Philipp Berndt; Sophie Dithmer; Hans C Helms; Dmytro Puchkov; Kavi Devraj; Mehmet Kaya; Zhihai Qin; Stefan Liebner; Hartwig Wolburg; Anuska V Andjelkovic; Andre Rex; Ingolf E Blasig; Reiner F Haseloff Journal: J Cereb Blood Flow Metab Date: 2020-02-13 Impact factor: 6.200
Authors: Nitesh Shashikanth; Marion M France; Ruyue Xiao; Xenia Haest; Heather E Rizzo; Jose Yeste; Johannes Reiner; Jerrold R Turner Journal: Nat Commun Date: 2022-06-30 Impact factor: 17.694
Authors: Laura Costea; Ádám Mészáros; Hannelore Bauer; Hans-Christian Bauer; Andreas Traweger; Imola Wilhelm; Attila E Farkas; István A Krizbai Journal: Int J Mol Sci Date: 2019-11-03 Impact factor: 5.923